TREATMENT OF NEONATAL ENCEPHALOPATHY WITH ORAL SILDENAFIL SUSPENSION TO REPAIR BRAIN INJURY SECONDARY TO BIRTH ASPHYXIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY (PHASE II STUDY)

Registry ID

SANE-03

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE

Start date

2023-08-11

Last update

2023-02-02

Conditions

• BRAIN INJURY

Related clinical trials

• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 EXPLORATORY STUDY TO EVALUATE THE NEUROPROTECTIVE EFFECTS OF AV-001 ON HEMODIALYSIS-INDUCED BRAIN INJURY VIA CEREBROVASCULAR STABILIZATION IN CHRONIC HEMODIALYSIS PATIENTS
• TREATMENT OF NEONATAL ENCEPHALOPATHY WITH ORAL SILDENAFIL SUSPENSION TO REPAIR BRAIN INJURY SECONDARY TO BIRTH ASPHYXIA: AN OPEN-LABEL DOSE-FINDING CLINICAL TRIAL (PHASE IB STUDY)

View on source registry